TP53 and breast cancer: A similar study by Rodriguez et al. used next-generation sequencing on matched plasma samples and fresh tissue biopsies from patients with primary breast cancer and found additional TP53 and PIK3CA mutations in ctDNA, which were not identified in the tissue biopsies [22].